Igf-1 and related compounds in pregnancy
CA 2087030 A1 · Owner: Ambler, Geoffrey R. · Inventors: Ambler, Geoffrey R.; Breier, Bernhard H.; Gluckman, Peter D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Fetal growth is promoted and fetal growth retardation is, reduced in mammals by increasing in a maternal host during pregnancy the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof. The active concentration of IGF-1 and/or IGF-2 and/or analogues thereof may be increased by administering such a compound to the maternal host, or by administering to the maternal host a compound, such as placental lactogen, which upon being so administered increases the active concentration of IGF-1 and/or IGF-2 and/or analogues thereof in the maternal host.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 10, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 10, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 10, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.